BCM
NTUS

Beddow Capital Management’s Natus Medical Inc NTUS Stock Holding History

Beddow Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,000
Closed -$205K – 59
2021
Q1 		$205K Buy
+8,000
New +$205K 0.13% 53
2020
Q1 		– Sell
-8,000
Closed -$264K – 54
2019
Q4 		$264K Hold
8,000
– – 0.16% 39
2019
Q3 		$255K Sell
8,000
-338
-4% -$9.85K 0.16% 40
2019
Q2 		$214K Hold
8,338
– – 0.12% 42
2019
Q1 		$212K Hold
8,338
– – 0.12% 43
2018
Q4 		$284K Sell
8,338
-5,710
-41% -$186K 0.16% 39
2018
Q3 		$501K Sell
14,048
-199,155
-93% -$7.03M 0.22% 34
2018
Q2 		$7.36M Sell
213,203
-775
-0.4% -$27.2K 3.06% 15
2018
Q1 		$7.2M Buy
213,978
+10,480
+5% +$332K 2.9% 14
2017
Q4 		$7.77M Sell
203,498
-3,530
-2% -$141K 3.15% 15
2017
Q3 		$7.76M Sell
207,028
-4,372
-2% -$154K 3.16% 14
2017
Q2 		$7.88M Buy
211,400
+19,385
+10% +$700K 3.19% 14
2017
Q1 		$7.54M Buy
192,015
+6,625
+4% +$249K 2.98% 16
2016
Q4 		$6.45M Buy
185,390
+11,035
+6% +$433K 2.57% 18
2016
Q3 		$6.85M Sell
174,355
-395
-0.2% -$15.8K 2.81% 16
2016
Q2 		$6.61M Buy
174,750
+25,735
+17% +$862K 2.75% 17
2016
Q1 		$5.73M Sell
149,015
-7,925
-5% -$295K 2.57% 17
2015
Q4 		$7.54M Sell
156,940
-73,055
-32% -$3.38M 3.32% 13
2015
Q3 		$9.07M Sell
229,995
-59,950
-21% -$2.55M 3.8% 9
2015
Q2 		$12.3M Sell
289,945
-54,195
-16% -$2.16M 4.32% 6
2015
Q1 		$13.6M Sell
344,140
-41,385
-11% -$1.53M 4.75% 6
2014
Q4 		$13.9M Sell
385,525
-16,800
-4% -$564K 4.38% 6
2014
Q3 		$11.9M Sell
402,325
-2,050
-0.5% -$56.6K 3.49% 11
2014
Q2 		$10.2M Buy
404,375
+250
+0.1% +$6.18K 2.77% 22
2014
Q1 		$10.4M Sell
404,125
-8,000
-2% -$202K 2.87% 20
2013
Q4 		$9.27M Sell
412,125
-7,875
-2% -$152K 2.6% 22
2013
Q3 		$5.96M Buy
420,000
+10,500
+3% +$140K 1.78% 28
2013
Q2 		$5.59M Buy
+409,500
New +$5.58M 1.81% 26

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Beddow Capital Management's NTUS Position: Q2 2021 in Review

Beddow Capital Management sold out of Natus Medical Inc (NTUS) in Q2 2021, closing a stake of 8,000 shares — an estimated $205K sold.

Beddow Capital Management first reported a position in NTUS in Q2 2013 and held it in 28 quarters. The position peaked at $13.9M in Q4 2014. 170 funds tracked by Wall St. Rank hold NTUS as of Q2 2021.

  • Beddow Capital Management reported no remaining Natus Medical Inc position as of Q2 2021 after selling out during the quarter.
  • Beddow Capital Management sold 8,000 Natus Medical Inc shares in Q2 2021, an estimated $205K.
  • Beddow Capital Management first reported a position in Natus Medical Inc in Q2 2013 and held it in 28 quarters.
  • Beddow Capital Management's Natus Medical Inc position peaked at $13.9M in Q4 2014.
  • 170 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2021.

Based on Beddow Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.